Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · Real-Time Price · USD
3.080
+0.060 (1.99%)
At close: Mar 28, 2025, 4:00 PM
3.210
+0.130 (4.22%)
After-hours: Mar 28, 2025, 5:56 PM EDT

Kiora Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Operating Revenue
16---0.01
Upgrade
Other Revenue
0.02----
Upgrade
Revenue
16.02---0.01
Upgrade
Revenue Growth (YoY)
-----99.55%
Upgrade
Cost of Revenue
0.380.413.455.353.27
Upgrade
Gross Profit
15.64-0.41-3.45-5.35-3.26
Upgrade
Selling, General & Admin
5.544.667.285.224.24
Upgrade
Research & Development
4.523.62---
Upgrade
Operating Expenses
10.168.287.285.224.24
Upgrade
Operating Income
5.48-8.69-10.73-10.57-7.51
Upgrade
Interest Expense
-0.02-0.01-0.01-0.01-0
Upgrade
Interest & Investment Income
1.250.170.0600.02
Upgrade
Other Non Operating Income (Expenses)
0.030.03-1.44--
Upgrade
EBT Excluding Unusual Items
6.73-8.5-12.12-10.58-7.49
Upgrade
Merger & Restructuring Charges
----0.1-0.41
Upgrade
Impairment of Goodwill
----4.04-
Upgrade
Gain (Loss) on Sale of Assets
-0-0.030-0.11
Upgrade
Other Unusual Items
0.94-1.99-1.580.750.94
Upgrade
Pretax Income
5.66-12.42-13.7-13.96-6.85
Upgrade
Income Tax Expense
2.070.09-0.11-0.190.01
Upgrade
Earnings From Continuing Operations
3.59-12.51-13.58-13.77-6.86
Upgrade
Net Income
3.59-12.51-13.58-13.77-6.86
Upgrade
Preferred Dividends & Other Adjustments
-0.53---
Upgrade
Net Income to Common
3.59-13.04-13.58-13.77-6.86
Upgrade
Shares Outstanding (Basic)
41000
Upgrade
Shares Outstanding (Diluted)
41000
Upgrade
Shares Change (YoY)
666.73%561.21%203.73%110.04%-
Upgrade
EPS (Basic)
0.93-24.25-166.94-514.04-538.01
Upgrade
EPS (Diluted)
0.87-24.25-166.94-514.04-538.01
Upgrade
Free Cash Flow
8.55-9.56-10.43-10.74-7.34
Upgrade
Free Cash Flow Per Share
2.07-17.76-128.16-400.88-575.29
Upgrade
Gross Margin
97.63%----
Upgrade
Operating Margin
34.19%----62238.67%
Upgrade
Profit Margin
22.44%----56901.65%
Upgrade
Free Cash Flow Margin
53.39%----60844.56%
Upgrade
EBITDA
5.6-8.64-10.69-10.53-7.47
Upgrade
EBITDA Margin
34.96%----
Upgrade
D&A For EBITDA
0.120.050.040.050.03
Upgrade
EBIT
5.48-8.69-10.73-10.57-7.51
Upgrade
EBIT Margin
34.19%----
Upgrade
Effective Tax Rate
36.49%----
Upgrade
Revenue as Reported
16.02----
Upgrade
Updated Mar 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q